BioSpace News Archive

Horizon Therapeutics plc announced that its fourth-quarter and full-year 2019 financial results will be released on Wednesday, Feb. 26, 2020.

Biotech Showcase, the investor conference driving therapeutic innovation, advances in digital medicine, and broad industry collaboration, had more than 3,800 attendees, marking rising participation every year since the first meeting 12 years ago.

Co-Chairs, Personalized Medicine Coalition Organize Introductory Briefing to Educate Congress, Public on Personalized Medicine’s Benefits of Earlier Detection, Targeted Treatment, Improved Prevention Strategies

The SPIE-Glebov UCF graduate student scholarship is part of a $2.5 million SPIE education funding initiative for optics and photonics

SIRION Biotech GmbH and InProTher Aps announced a broad licensing agreement which includes coverage of SIRION’s adenovirus technologies to cancer vaccines encoding Endogenous Retrovirus -derived antigens for active immunotherapy.

Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced that CEO Nadav Kidron will present a company overview at the BIO CEO & Investor Conference in New York City.

Crown Bioscience announced the presentation of new NAFLD/NASH data with Yale School of Medicine.

OncoSec Medical Incorporated, a company developing late-stage intratumoral cancer immunotherapies, announced the publication of data showing that TAVO™ treatment, administered through OncoSec’s electroporation gene delivery system, resulted in regression of injected and non-injected Merkel cell carcinoma tumors.

- Preclinical data show unique platform addresses vascular leakage, which may support the health of patients during coronavirus infection

Contact-Free Continuous Monitoring Shown to be Valuable in Detecting Abnormal Patterns and Reducing Failure-to-Rescue Events